Endpoints News

Zynlonta's confirmatory data		Read in browser

Thank you for reading, dupa dupackia!

basic

UPGRADE

M T W Thu F

4 June, 2026

A year ago, biotech was in its bleakest stretch in a decade. Now IPOs are rebounding and China deals are heating up. John Carroll and a panel of industry leaders dig into the latest Endpoints 100 results and uncover what’s next for the sector.

news

Alnylam signs its first AI discovery deal with RNA specialist Inceptive

ADC Therapeutics' confirmatory data for Zynlonta muddied by death rates

ADC biotech Ona Therapeutics secures $86.6M in Series B raise

Jun 11

11:00 am ET

Data-driven manufacturing: Enhancing process robustness across sites

sponsored by Samsung Biologics

Senior Director, Licensing Officer

Bayer

Cambridge, MA, USA

Director, Government Pricing

Sandoz

Princeton, NJ, USA

Recruit talent with Endpoints Careers

Contact Meg Estacio: mestacio@endpointsnews.com

LGBTQ+ diversity drives innovation in biopharma — but transgender and non-binary professionals face rising challenges. Endpoints is going live with our fourth annual special report celebrating the honorees giving voice and visibility while forging ahead across life sciences. Join us.

Pharma

Bristol Myers turns focus to AI costs after broad rollout to workers

Explaining unapproved drugs to payors: FDA offers pharma new guidance to avoid pitfalls

Axsome pushes back generic entry for narcolepsy drug until 2040

in case you missed it

Mineralys makes money moves before looming hypertension approval

Regeneron doubles down on CytomX after other pharmas walked away

Lilly strikes Ascidian deal worth up to $1.9B for RNA editing in kidney diseases

Lila Sciences said in talks for funds at $8.5 billion valuation

White House proposes vast overhaul of US science funding: what you need to know

In case you missed it, Bristol Myers CEO Chris Boerner said the company is calculating the ROI on its AI initiatives. "We're trying to rein some of it in to be sure we're being thoughtful about investing," he said at an AI event in California. Read more from Drew Armstrong.

Reynald Castaneda

Deputy Editor, Endpoints News

2029 Becker Drive; Lawrence, Kansas 66047 USA Privacy and deletion: help@endpointsnews.com